|
|
DSM Sinochem Pharmaceuticals appoints
Anurag Roy as its new Business Unit Director Asia Pacific, Middle East and
Africa
DSM
Sinochem Pharmaceuticals, the global leader in
sustainable antibiotics, next generation statins and anti-fungals, has appointed Anurag Roy as its new Business
Unit Director for Asia Pacific, Middle East and Africa. He will also be the Global Product Owner, New API.
Anurag
is a seasoned chemical, pharmaceutical and life sciences industry professional,
having acquired a wealth of business and product management experience during
his 17 years of strategic, operational and financial leadership.
He has an
excellent track record in uniquely challenging global and indigenous business
environments, specifically in forging strategic
partnerships with innovators, driving organizational profit and establishing
credibility.
 |
| Anurag Roy, Business Unit Director for Asia Pacific, Middle East and Africa |
Anurag has previously held senior management positions at various
companies, most recently as Vice President, Custom Pharmaceuticals Services,
Dr. Reddy’s Laboratories (DRL). He also has experience of escalating business
growth at three US-based companies, BASE-SAF, a chemical manufacturer; ORC
International, a market research consultancy and Frost and Sullivan, the global
growth consulting firm.
His areas of expertise have, therefore, encompassed
driving business, strategic marketing, and motivating cross functional global
teams for peak performance, mergers, acquisitions and new ventures.
Anurag
holds an MBA from Columbia Business School, New York, USA. He has authored
several articles which have appeared in leading publications such as LA Times,
Chemical Week, Modern Plastics, International Journal of Polymer Sciences,
Economic Times & Business India. He has also presented scientific papers
and has been a key spokesperson at several international conferences.
DSM Sinochem Pharmaceuticals
(DSP) is the global leader in sustainable
antibiotics, next generation statins and anti-fungals. DSP develops, produces
and sells raw materials, intermediates, active pharmaceutical ingredients and
drug products.
Our employees worldwide work together to deliver cutting edge
generics solutions that help to keep customers ahead of the
competition.
Headquartered in Singapore, the group has operations in China,
India, Egypt, the Netherlands, Spain, the US and Mexico. DSP is a 50/50 Joint
Venture of Royal DSM, a global science-based company active in health,
nutrition and materials, and Sinochem Group, a Fortune 500 enterprise.
DSM Sinochem Pharmaceuticals
Business Unit AMEA
email info@dsm-sinochem.com
www.dsm-sinochem.com
|
For more
information, please contact:
|
DSMSinochem Pharmaceuticals
|
Avian Media
|
|
S Suman
Sharma: + 91 – 96195 52810
|
Krishna: +91-9442191717
Srinija, +91 - 9789059528
|
No comments:
Post a Comment